Introduction {#sec1}
============

Recent development of glycobiology^[@ref1]^ has increased the need for the synthesis of structurally defined carbohydrates and their analogues. Among them, *C*-glycosides^[@ref2]^ are important analogues of carbohydrates, which exhibit high stability toward chemical and enzymatic hydrolysis and include many bioactive natural products^[@ref3]^ and commercial drugs.^[@ref4]^ Because of their stability and broad range of biological activities, access to *C*-glycosides is of great importance.

Several common synthetic approaches,^[@cit2e],[@cit2f],[@cit3b]^ including methods using cationic, anionic, or radical sugar species, as well as methods using de novo construction of the sugar or aromatic moiety for the synthesis of aryl-*C*-glycoside scaffolds, were used in the past. However, these methods are often hard to carry out stereoselectively and are not universal across sugar substrates. Therefore, alternative approaches including transition-metal-mediated cross-coupling reactions^[@cit2e],[@cit2f],[@cit3b]^ (Heck, Suzuki, Stille, and Negishi-type reactions) have been developed for the synthesis of *C*-glycosides employing metalated glycals and aromatic electrophiles as key starting materials. Nevertheless, the preparation of 1-metalated glycals usually relies upon the lithiation of the C-1 position of protected glycals by a strong base. Lithiation conditions are harsh, and some common protecting groups such as benzyl^[@cit5a]^ or *tert*-butyldimethylsilyl (TBS)^[@cit5b],[@cit5c]^ ethers compete for lithiation. Several protecting groups that survive the metalation of glycals by *t*-BuLi have been gradually developed (triisopropylsilyl,^[@ref6]^ di-*tert*-butylsilylene,^[@cit6b],[@cit6c],[@ref7]^ TBS,^[@ref5],[@cit6c],[@ref8]^*tert*-butyldiphenylsilyl,^[@cit5a],[@ref9]^ triethylsiyl,^[@ref10]^ methoxymethyl (MOM),^[@ref7],[@ref11]^ and isopropylidene^[@ref11],[@ref12]^), but they all suffer from one or more disadvantages, which precludes their general applicability ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). These include, for example, the requirement of 3--6 equiv of *t*-BuLi for glycal deprotonation, presumably due to complexation effects. Besides that, the deprotection of silyl ethers with tetra-*n*-butylammonium fluoride is usually complicated by problems in separating the product from tetrabutylammonium salts. Moreover, silyl ethers are not universal protecting groups across pyranoid substrates ([d]{.smallcaps}-glucal, [d]{.smallcaps}-galactal, etc.), which makes it necessary to discover the efficient combination of protecting groups for each application. Next, silyl groups are quite expensive for multigram synthesis and the combination of MOM and isopropylidene groups requires multistep protection. Finally, silyl ether-protected cross-coupling products are often inconvenient for further transformation to α- or β-*C*-glycosides, presumably due to the bulkiness of the protecting groups and for ring-strain reasons.^[@cit6b],[@ref13]^ In view of the aforementioned, it is obvious that the development of alternative protection strategies would facilitate progress in the synthesis of aryl-*C*-glycosides from glycals.

![Protecting groups that survive metalation of [d]{.smallcaps}-glucal and [d]{.smallcaps}-galactal by *t*-BuLi.](ao-2018-009016_0004){#fig1}

Results and Discussion {#sec2}
======================

We have found that the utilization of rarely used ethoxyethyl^[@ref14]^ (EE) or methoxypropyl^[@ref15]^ (MOP) acetal protecting groups ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}) offers several advantages. Although these protecting groups have been used for orthogonal protection in carbohydrate chemistry, their use for glycals has not yet been described. Specifically, EE and MOP protecting groups are cheap and enable mild conditions for their introduction and removal. Nevertheless, they are stable under strong basic conditions. This article suggests that EE and MOP can be universal protecting groups across pyranoid glycals and convenient for further transformation of cross-coupling products to the corresponding α- or β-*C*-glycosides.

First, we investigated the reaction conditions for the preparation of fully protected glycals **2a**--**b** and **3a**--**b**. Specifically, we investigated commercially available [d]{.smallcaps}-glucal **1a** and [d]{.smallcaps}-galactal **1b**, which reacted under standard conditions with 2-methoxypropene^[@ref16]^ or ethyl vinyl ether^[@ref17]^ in the presence of pyridinium tosylate, yielding fully protected glycals **2a**--**b** and **3a**--**b** in 79--95% yields. Remarkably, the reaction of 2-methoxypropene with *cis*-1,2-diol such as [d]{.smallcaps}-galactal **1b** leads to the formation of isopropylidene acetal on the secondary hydroxyls (**3a**), whereas the reaction with *trans*-1,2-diol such as [d]{.smallcaps}-glucal **1a** introduces MOP groups selectively. In the reaction with ethyl vinyl ether, no such selectivity has been observed and per-EE products have been obtained in both cases ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). Surprisingly, the subsequent reaction of **3a** with *t*-BuLi formed racemic open-chain enone **4** in 81% yield (the enantiomeric composition was determined by derivatization by (*S*)-Mosher's acid and NMR analysis (see Supporting Information ([SI](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b00901/suppl_file/ao8b00901_si_001.pdf)) Chapter 2, [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"})).

![Preparation of MOP- and EE-Protected [d]{.smallcaps}-Glycals **2a**--**b** and **3a**--**b**^,^\
2-Methoxypropene, Py·TsOH, dichloromethane (DCM), or dimethylformamide (DMF); 0--25 °C; 1--12 h.\
Ethyl vinyl ether, Py·TsOH, DCM; 0--25 °C; 1.5--12 h.](ao-2018-009016_0007){#sch1}

![Reaction of **3a** with *t*-BuLi](ao-2018-009016_0008){#sch2}

Next, since the protection of glycals with ethyl vinyl ether produced fully protected glycals as a mixture of eight possible diastereoisomers, it was crucial to find a simple and efficient method to prove the structure of these compounds by NMR. Therefore, we first attempted to deprotect EE glycals **2b** and **3b** using 5% (v/v) trifluoroacetic acid (TFA) in MeOH-*d*~4~ directly in the NMR tube; however, this method suffered from partial decomposition of substrates. Fortunately, switching the 5% TFA to 10% (v/v) CD~3~COOD in MeOH-*d*~4~ and heating the mixture to 50 °C for 0.75--2 h in the NMR tube enabled the complete cleavage of EE groups. Using this in situ deprotection protocol, we were able to confirm the structure of EE-protected compounds by NMR (for details, see the [SI](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b00901/suppl_file/ao8b00901_si_001.pdf), Chapter 4).

Since our interest was focused on the synthesis of *C*-glycosides using Suzuki and Stille reactions, fully protected [d]{.smallcaps}-glucals **2a**--**b** and [d]{.smallcaps}-galactal **3b** were converted into 1-lithiated intermediates by treatment with *t*-BuLi and then reacted with Bu~3~SnCl or *i*PrOBPin, followed by quenching with water. In all cases ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 1--6), the reaction proceeded cleanly, providing the desired compounds **5a**--**b**, **6a**--**b**, **7**, and **8** in almost quantitative yields ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). The deprotonation of vinylic C1--H by *t*-BuLi usually requires 3--6 equiv of base.^[@ref18]^ Therefore, it was important to find the optimal lithiation conditions for the preparation of organometalated glycals with EE and MOP protecting groups. We performed a series of lithiation experiments on protected [d]{.smallcaps}-glucals **2a**--**b** with *t*-BuLi, followed by deuteration with D~2~O. In both cases, direct deprotonations of C1--H required 3.5 equiv of *t*-BuLi (see the [SI](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b00901/suppl_file/ao8b00901_si_001.pdf), Chapter 1). No evidence of competing deprotonation on MOP or EE protecting groups was observed.

###### Preparation of Metalated Glycals **5a**--**b** or **6a**--**b** and **7**--**8**

![](ao-2018-009016_0003){#fx1}

  entry   derivative                         PG    E^+^         E         product, yield (%)
  ------- ---------------------------------- ----- ------------ --------- ----------------------------------------------
  1       [d]{.smallcaps}-glucal, **2a**     MOP   *i*PrOBPin   BPin      **5a**, (94)[a](#t1fn1){ref-type="table-fn"}
  2       [d]{.smallcaps}-glucal, **2a**     MOP   Bu~3~SnCl    SnBu~3~   **6a**, (93)[b](#t1fn2){ref-type="table-fn"}
  3       [d]{.smallcaps}-glucal, **2b**     EE    *i*PrOBPin   BPin      **5b**, (81)[a](#t1fn1){ref-type="table-fn"}
  4       [d]{.smallcaps}-glucal, **2b**     EE    Bu~3~SnCl    SnBu~3~   **6b**, (90)[b](#t1fn2){ref-type="table-fn"}
  5       [d]{.smallcaps}-galactal, **3b**   EE    *i*PrOBPin   BPin      **7**, (90)[a](#t1fn1){ref-type="table-fn"}
  6       [d]{.smallcaps}-galactal, **3b**   EE    Bu~3~SnCl    SnBu~3~   **8**, (69)[b](#t1fn2){ref-type="table-fn"}

Crude product.

Isolated yield.

In our systematic study of EE and MOP protecting groups, we also tested the performance of the substituted glycals **5a**--**b**, **6a**--**b**, **7**, and **8** in cross-coupling reactions. As model reactions, we investigated Suzuki--Miyaura and Stille reactions with 1-iodonaphthalene ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). The Suzuki--Miyaura reaction of 1-pinacolboronates **5a**, **5b**, and **7** was performed under our previously published conditions^[@cit6c]^ (conditions A). In all cases, the expected cross-coupling products **9a**, **9b**, and **10** were obtained in high yields of 72--93% ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entries 1, 3, and 5).

###### Preparation of Protected 1-Naphthyl-*C*-glycals **9a**--**b** and **10**

![](ao-2018-009016_0001){#fx2}

  entry   derivative   PG    E         conditions   product, yield (%)[a](#t2fn1){ref-type="table-fn"}
  ------- ------------ ----- --------- ------------ ----------------------------------------------------
  1       **5a**       MOP   BPin      A            **9a**, (86)
  2       **6a**       MOP   SnBu~3~   B            **9a**, (76)
  3       **5b**       EE    BPin      A            **9b**, (79)
  4       **6b**       EE    SnBu~3~   B            **9b**, (93)
  5       **7**        EE    BPin      A            **10**, (72)
  6       **8**        EE    SnBu~3~   B            **10**, (87)
  7       **2b**       EE    H         C            **9b**, (43)
  8       **2b**       EE    H         D            **9b**, (20)

Isolated yield; reaction conditions: (A) Pd(PPh~3~)~2~Cl~2~, 1,2-dimethoxyethane (DME), Na~2~CO~3~, 80 °C; (B) Pd(PPh~3~)~4~, toluene, 120 °C; (C) (1) *t*-BuLi, InCl~3~, tetrahydrofuran (THF), (2) Pd(Ph~3~P)~2~Cl~2~, reflux; (D) (1) *t*-BuLi, ZnCl~2~, THF, (2) Pd(Ph~3~P)~4~.

The Stille reaction was carried out under standard conditions.^[@ref19]^ Specifically, Pd(PPh~3~)~4~ was used as a catalyst and the reaction was heated at 120 °C for 12 h in toluene as the solvent. In these cases, the corresponding 1-stannylglycals **6a**, **6b**, and **8** were again converted to naphthyl-*C*-glycals **9a**, **9b**, and **10** in high yields of 72--86% ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entries 2, 4, and 6). Finally, we decided to prove the compatibility of the EE protecting groups of **2b** in Negishi-type^[@ref20]^ and In-mediated^[@cit6a]^ coupling reactions with 1-iodonaphthalene ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entries 7 and 8). In both cases, the cross-coupling product **9b** was isolated in 20--43% yields. These low yields were probably caused by the instability of EE protecting groups in the presence of zinc and indium Lewis acids after quenching with water.

In the next step, we investigated whether these protected cross-coupling products **9a**, **9b**, and **10** with a reactive endocyclic double bond can be deprotected without damaging the glycal double bond. To our surprise, the fully protected gluco derivative **9a** with MOP protecting groups was converted to free enol ether **12** by stirring in the mixture of 1% acetic acid and THF overnight. Similarly, the free cross-coupling product **12** was achieved after the treatment of the EE-protected derivative **9b** with a mixture of 20% aqueous acetic acid and THF ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}).

Since the control of the stereochemistry of *C*-glycosides is essential for the preparation of the desired stereoisomer, it was necessary to confirm that the EE- and MOP-protected derivatives **9a**--**b** are stable during stereoselective transformations,^[@cit6c],[@ref21]^ leading to α**-** or β-aryl-*C*-glycosides. Compounds **9a** and **9b** with MOP and EE protecting groups served as model compounds. It was found that hydroboration of the double bond in **9a** and **9b** with the BH~3~·THF complex followed by oxidation with alkaline hydrogen peroxide and deprotection with diluted acetic acid in THF gave directly aryl-β-*C*-glycoside **11** as a single stereoisomer in high overall yields ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). The opposite anomer, naphthyl-α-*C*-glycoside **13**, was obtained by epoxidation of the double bond with dimethyldioxirane (DMDO), followed by the cleavage of the formed epoxide ring with lithiumtriethylborohydride (LiBEt~3~H). The stereochemical outcome of these transformations is consistent with results previously reported on the substituted glucal unit bearing benzyl ether^[@ref21],[@cit22b]^ or silyl ether^[@cit6b],[@cit6c]^ protection. The reactions mentioned above were also carried out with the free cross-coupling product **12**; after hydroboration, β-*C*-glycoside **11** was obtained in high 84% yield ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). On the other hand, the transformation of **12** to α-anomer **13** failed.

![Transformations of the Glucal Double Bond to α- or β-Aryl-*C*-glucosides **11** or **13**^,^\
1% AcOH/THF (1:1).\
20% AcOH/THF (1:1).](ao-2018-009016_0005){#sch3}

Finally, the protected 1-naphthylgalactal **10** was subjected to subsequent stereoselective transformation. As we assumed, hydroboration of derivative **10** with the BH~3~.THF complex and deprotection with a mixture of 20% aqueous acetic acid and THF provided free aryl-β-*C*-glycoside **14** in 69% overall yield ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}).

![Preparation of Aryl-*C*-galactosides **14** and **16**^,^\
10% AcOH in MeOH.\
20% AcOH/MeOH (1:1).](ao-2018-009016_0006){#sch4}

Additionally, we also tested the Werz protocol,^[@ref22]^ which was supposed to lead to β-aryl*-C*-galactoside **14** using DIBAL-H and LiAlH~4~ for the opening of the epoxide ring. In both of these cases, the expected derivative **14** was obtained after deprotection. The free aryl-β-*C*-glycoside **14** was also obtained by the hydroboration of the free cross-coupling product **15**. As before, we decided to transform the coupled product **10** to the opposite naphthyl-α-*C*-glycoside. Although the product of the DMDO epoxidation of derivative **10** was confirmed, the subsequent opening of the formed epoxide ring with lithiumtriethylborohydride failed and derivative **16** with an opened galactose ring was isolated under the standard deprotection conditions. Even though various attempts to modify reaction conditions, workup procedures, and hydride sources were made, the desired α-*C*-galactoside with a closed sugar ring was not obtained ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}).

Conclusions {#sec3}
===========

In conclusion, we have introduced ethoxyethyl and methoxypropyl acetals as effective protecting groups for a straightforward and stereoselective synthesis of α- or β-naphthyl-*C*-glycosides. We have established that uniformly EE- and MOP-protected [d]{.smallcaps}-glycals are compatible with harsh basic conditions and are universal protecting groups for both [d]{.smallcaps}-glucal and [d]{.smallcaps}-galactal. Their stability was also proven in the subsequent Pd-catalyzed cross-coupling reactions and the ensuing oxidative−reductive transformation. We have also found that the complete removal of all EE or MOP groups is high yielding and effective under mild acidic conditions. We assume that this work can be extended to the synthesis of a wide range of aryl-*C*-glycosides.

Experimental Section {#sec4}
====================

General Experiment {#sec4.1}
------------------

All reactions using anhydrous conditions were performed using flame-dried apparatus under an atmosphere of argon. Standard inert techniques were used in handling all air and moisture sensitive reagents. Anhydrous THF and CH~2~Cl~2~ were obtained by distillation using CaH~2~ as a drying agent. Other anhydrous solvents were used directly as received from commercial suppliers. All other solvents were used as supplied (Analytical or high-performance liquid chromatography grade), without prior purification. Reagents were purchased from various commercial suppliers and used as supplied, unless otherwise indicated. Distilled water was used for chemical reactions. "Hexane" refers to the fraction of hexane boiling in the range 68--72 °C. Brine refers to a saturated solution of sodium chloride. Anhydrous magnesium sulfate (MgSO~4~) was used as a drying agent after reaction workup, as indicated.

Solution of DMDO in acetone was obtained according to a literature procedure,^[@ref23]^ stored at −20 °C under argon atmosphere, and used in 2 days after distillation at the latest. Column chromatography was carried out using Material Harvest silica gel (pore size 60 Å, mesh 230--400 (40--63 μm)). Thin-layer chromatography (TLC) was carried out using Merck TLC Silica gel 60 F~254~ aluminum plates. Visualization of the TLC plates was achieved using a UV lamp Spektroline-ENF-240/F (Spectronics Corporation Westbury) (λ~max~ = 254 nm) and/or by spraying with cerium(IV) sulfate solution (1% in 10% H~2~SO~4~). Mobile phases are reported in relative composition (e.g., hexane/EtOAc 1:1 *v*/*v*). All ^1^H and ^13^C NMR spectra were recorded using a Bruker Avance III 400 (401.0 MHz for ^1^H; 100.8 MHz for ^13^C) or Bruker Avance III 500 (500.0 MHz for ^1^H; 125.7 MHz for ^13^C) spectrometers. ^1^H and ^13^C resonances were fully assigned using H,H-COSY, H,C-HSQC, and H,C-HMBC techniques. All chemical shifts are quoted on the δ scale in ppm and referenced using residual ^1^H solvent signal in ^1^H NMR spectra (δ(CHCl~3~) = 7.26 ppm, δ(CD~2~HOD) = 3.31 ppm, δ(CD~2~HCOCD~3~) = 2.05 ppm, and δ(CD~2~HSOCD~3~) = 2.50 ppm) and ^13^C solvent signal in ^13^C NMR spectra (δ(CDCl~3~) = 77.0 ppm, δ(CD~3~OD) = 49.0 ppm, δ(CD~3~COCD~3~) = 29.8 ppm, and δ((CD~3~)~2~SO) = 29.7 ppm). Coupling constant (*J*) is reported in Hz with the following splitting abbreviations: s = singlet, d = doublet, t = triplet, q = quartet, and m = multiplet. IR spectra were recorded on a Thermo Scientific Nicolet 6700 spectrometer. Absorption maxima (υ~max~) are reported in wavenumbers (cm^--1^).

High-resolution mass spectra were measured on a LTQ Orbitrap XL (Thermo Fisher Scientific) spectrometer using electrospray ionization technique. Nominal and exact *m*/*z* values are reported in Daltons.

Optical rotations were measured on an AUTOPOL IV (Rudolph Research Analytical,) polarimeter at temperature 20 °C and 589 nm sodium line with a path length *l* of 1.0 dm. Concentration *c* is given in g/100 mL. Specific rotation values are reported as a unitless number with implied units of (deg mL)/(g dm). Melting points (mp) were recorded on a Kofler hot-stage microscope and are reported uncorrected in degrees Celsius (°C).

### 1,5-Anhydro-3,4,6-tri-*O*-(2-methoxypropan-2-yl)-[d]{.smallcaps}-arabino-hex-1-enitol (**2a**) {#sec4.1.1}

To a stirred solution of [d]{.smallcaps}-glucal **1a** (5 g, 34.21 mmol, 1 equiv) in anhydrous CH~2~Cl~2~ (50 mL) were added 2-methoxypropene (19.66 mL, 205.28 mmol, 6 equiv) and Pyr·TsOH (860 mg, 3.42 mmol, 0.10 equiv) at 0 °C under an argon atmosphere. The resulting heterogeneous reaction mixture was stirred for 3 h at the same temperature, during which it turned homogeneous. Et~3~N (5 mL) was added, and the resulting mixture was stirred for another 20 min at room temperature (RT) and then diluted with CH~2~Cl~2~ (300 mL). The organic layer was washed with H~2~O (3 × 200 mL), dried over MgSO~4~, filtered, and concentrated in vacuo. The residue was purified by column chromatography on silica gel (hexane/EtOAc 15:1, 1% Et~3~N) to give MOP-glucal **2a** (10.46 g, 84%) as a colorless oil: *R~f~* = 0.47 (hexane/EtOAc 4:1); \[α\]~D~^20^ −28.6 (*c* 0.3, CHCl~3~); ^1^H NMR (401.0 MHz, DMSO-*d*~6~): 1.24, 1.245, 1.25, 1.29, 1.30 (5 × s, 18H, (CH~3~)~2~C); 3.09, 3.15 (2 × s, 9H, CH~3~O); 3.47 (dd, 1H, *J*~6b,6a~ = 10.7, *J*~6b,5~ = 4.3, H-6b); 3.67 (dd, 1H, *J*~6a,6b~ = 10.7, *J*~6a,5~ = 8.2, H-6a); 3.80 (dt, 1H, *J*~3,2~ = 5.3, *J*~3,4~ = *J*~3,5~ = 2.0, H-3); 3.94 (td, 1H, *J*~4,3~ = *J*~4,5~ = 2.0, *J*~4,2~ = 1.6, H-4); 4.14 (ddt, 1H, *J*~5,6a~ = 8.2, *J*~5,6b~ = 4.3, *J*~5,4~ = 2.0, H-5); 4.75 (ddd, 1H, *J*~2,1~ = 6.4, *J*~2,3~ = 5.3, *J*~2,4~ = 1.6, H-2); 6.38 (d, 1H, *J*~1,2~ = 6.4, H-1); ^13^C NMR (100.8 MHz, DMSO-*d*~6~): 24.3, 24.5, 25.0, 25.05, 25.08, 25.2 ((**C**H~3~)~2~C); 47.8, 48.7, 49.0 (CH~3~O); 58.9 (CH~2~-6); 61.6 (CH-3); 67.2 (CH-4); 76.9 (CH-5); 99.5, 100.3 ((CH~3~)~2~**C**); 100.4 (CH-2); 101.0 ((CH~3~)~2~**C**); 143.5 (CH-1); IR (CHCl~3~): ν~max~ 3069, 2996, 2945, 2832, 1647, 1464, 1382, 1373, 1250, 1184, 1151, 1097, 1070, 1044, 1027, 1014, 909, 864, 839, 572, 528, 505 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\]^+^ calcd for C~18~H~34~O~7~Na 385.2197, found 385.2198.

### 1,5-Anhydro-3,4,6-tri-*O*-(ethoxyethyl)-[d]{.smallcaps}-arabino-hex-1-enitol (**2b**) {#sec4.1.2}

To a stirred solution of [d]{.smallcaps}-glucal **1a** (2 g, 13.69 mmol, 1 equiv) in anhydrous CH~2~Cl~2~ (30 mL) were added ethyl vinyl ether (7.86 mL, 82.11 mmol, 6 equiv) and Pyr·TsOH (344 mg, 1.37 mmol, 0.10 equiv) at 0 °C under an argon atmosphere. The resulting heterogeneous reaction mixture was stirred for 20 h at room temperature, during which it turned homogeneous. The resulting mixture was diluted with CH~2~Cl~2~ (250 mL). The organic layer was washed with H~2~O (3 × 200 mL), dried over MgSO~4~, filtered, and concentrated in vacuo. The residue was purified by column chromatography on silica gel (hexane/EtOAc 6:1 to 3:1) to give EE-glucal **2b** (4.7 g, 95%) as a colorless oil: *R~f~* = 0.53 (hexane/EtOAc 3:1); ^1^H NMR (401.0 MHz, CDCl~3~): 1.16--1.21 (m, 9H, C**H**~**3**~CH~2~O); 1.28--1.34 (m, 9H, C**H**~**3**~CH); 3.43--3.94 (m, 8H, H-4,6, CH~3~C**H**~**2**~O); 4.03--4.20 (m, 2H, H-3,5); 4.69--5.00 (m, 4H, H-2, CH~3~C**H**); 6.35--6.43 (m, 1H, H-1); ^13^C NMR (100.8 MHz, CDCl~3~): 15.19, 15.22, 15.24, 15.27, 15.28, 15.30, 15.31 (**C**H~3~CH~2~O); 19.73, 19.76, 19.77, 19.78, 19.80, 19.83, 20.30, 20.31, 20.33, 20.34, 20.42, 20.44, 20.51, 20.55, 20.57, 20.58, 20.60 (**C**H~3~CH); 59.84, 59.87, 59.88, 60.41, 60.43, 60.57, 60.81, 60.84, 60.86, 60.97, 61.03, 61.06, 61.18, 61.26, 61.27, 61.29, 61.35, 61.40, 61.54, 61.79 (CH~3~**C**H~2~O); 62.68, 63.14, 63.16, 63.22, 63.31, 63.86, 63.89 (CH~2~-6); 67.47, 67.80, 69.18, 69.32, 70.26, 70.63, 70.73, 70.85, 71.12, 71.14, 71.18, 71.37, 71.38, 72.22, 72.49 (CH-3,4); 76.38, 76.41, 76.47, 76.81, 76.84, 76.98 (CH-5); 97.31, 97.32, 97.50, 98.63, 98.83, 99.05, 99.12, 99.43, 99.45, 99.56, 99.58, 99.63, 99.68, 99.73, 99.77, 99.82, 99.85, 99.93, 99.95, 100.05, 100.11, 100.17, 100.28, 100.35, 100.52, 100.79, 100.86, 100.93 (CH-2, CH~3~**C**H); 144.00, 144.09, 144.24 (CH-1); IR (CHCl~3~): ν~max~ 3070, 2981, 2933, 2898, 2886, 1948, 1445, 1383, 1341, 1239, 1131, 1096, 1084, 1055, 971, 949, 930, 877, 844, 819 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\]^+^ calcd for C~18~H~34~O~7~Na 385.2197, found 385.2198.

### 1,5-Anhydro-2-deoxy-3,4-*O*-isopropylidene-6-*O*-(2-methoxypropan-2-yl)-[d]{.smallcaps}-lyxo-hex-1-enitol (**3a**) {#sec4.1.3}

To a stirred solution of [d]{.smallcaps}-galactal **1b** (2 g, 13.69 mmol, 1 equiv) in anhydrous DMF (15 mL) were added 2-methoxypropene (3.93 mL, 41.06 mmol, 3 equiv) and Pyr·TsOH (172 mg, 684 μmol, 0.05 equiv) at 0 °C under an argon atmosphere. The resulting mixture was stirred for 1 h at the same temperature, and then another portion of 2-methoxypropene (2.62 mL, 27.37 mmol, 2 equiv) was added. The reaction mixture was stirred for another 2 h at 0 °C. Et~3~N (3 mL) was added, and the resulting mixture was diluted with EtOAc (200 mL) and then washed with H~2~O (300 mL). The aqueous phase was washed with EtOAc (3 × 150 mL), and the combined organic phases were dried over MgSO~4~, filtered, and concentrated in vacuo. The residue was purified by column chromatography on silica gel (hexane/EtOAc 15:1 to 10:1, 1% Et~3~N) to give product **3a** (2.78 g, 79%) as a pale yellow oil: *R~f~* = 0.65 (hexane/EtOAc 3:1); \[α\]~D~^20^ −3.2 (*c* 0.4, CHCl~3~); ^1^H NMR (401.0 MHz, DMSO-*d*~6~): 1.26 (q, 3H, ^4^*J* = 0.6, (CH~3~)~2~C); 1.27 (s, 6H, (CH~3~)~2~C); 1.34 (q, 3H, ^4^*J* = 0.6, (CH~3~)~2~C); 3.11 (s, 3H, CH~3~O); 3.50--3.62 (m, 2H, H-6); 3.99 (ddd, 1H, *J*~5,6~ = 7.0, 5.7, *J*~5,4~ = 1.5, H-5); 4.29 (dtd, 1H, *J*~4,3~ = 6.1, *J*~4,2~ = *J*~4,5~ = 1.5, *J*~4,1~ = 0.4, H-4); 4.63 (dd, 1H, *J*~3,4~ = 6.1, *J*~3,2~ = 2.9, H-3); 4.71 (ddd, 1H, *J*~2,1~ = 6.2, *J*~2,3~ = 2.9, *J*~2,4~ = 1.5, H-2); 6.41 (dd, 1H, *J*~1,2~ = 6.2, *J*~1,4~ = 0.4, H-1); ^13^C NMR (100.8 MHz, DMSO-*d*~6~): 24.39, 24.40, 26.9, 28.3 ((**C**H~3~)~2~C); 60.7 (CH~2~-6); 68.1 (CH-3); 72.3 (CH-4); 73.7 (CH-5); 99.8 ((CH~3~)~2~**C**); 102.8 (CH-2); 109.6 ((CH~3~)~2~**C**); 144.5 (CH-1); IR (CHCl~3~): ν~max~ 3442, 3065, 2989, 2940, 2892, 2831, 1727, 1648, 1459, 1437, 1380, 1371, 1260, 1239, 1214, 1185, 1164, 1153, 1126, 1088, 1068, 1054, 1032, 993, 868, 843, 755, 720, 676, 661, 597, 560, 536, 500 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\]^+^ calcd for C~13~H~22~O~5~Na 281.1359, found 281.1360.

### 1,5-Anhydro-2-deoxy-3,4,6-tri-*O*-(ethoxyethyl)-[d]{.smallcaps}-lyxo-hex-1-enitol (**3b**) {#sec4.1.4}

To a stirred solution of [d]{.smallcaps}-galactal **1a** (5 g, 34.21 mmol, 1 equiv) in anhydrous CH~2~Cl~2~ (40 mL) were added ethyl vinyl ether (26.21 mL, 273.71 mmol, 8 equiv) and Pyr·TsOH (860 mg, 3.42 mmol, 0.10 equiv) at 0 °C under an argon atmosphere. The resulting heterogeneous reaction mixture was stirred for 20 h at room temperature, during which it turned homogeneous. The resulting mixture was diluted with CH~2~Cl~2~ (200 mL). The organic layer was washed with H~2~O (3 × 150 mL), dried over MgSO~4~, filtered, and concentrated in vacuo. The residue was purified by column chromatography on silica gel (hexane/EtOAc 10:1 to 4:1) to give EE-galactal **3b** (10.75 g, 87%) as a colorless oil: *R~f~* = 0.41 (hexane/EtOAc 4:1); ^1^H NMR (500.0 MHz, CDCl~3~): 1.16--1.21 (m, 9H, C**H**~3~CH~2~O); 1.29--1.36 (m, 9H, C**H**~3~CH); 3.43--4.00 (m, 8H, H-6, CH~3~C**H**~2~O); 4.00--4.38 (m, 3H, H-3,4,5); 4.68--4.87 (m, 3H, CH~3~C**H**); 4.88--5.06 (m, 1H, H-2); 6.29--6.37 (m, 1H, H-1); ^13^C NMR (125.7 MHz, CDCl~3~): 15.22, 15.23, 15.24, 15.25, 15.27, 15.28, 15.31, 15.32, 15.34, 15.36, 15.39, 15.41 (**C**H~3~CH~2~O); 19.81, 19.82, 19.84, 19.88, 19.90, 19.94, 19.99, 20.00, 20.01, 20.06, 20.08, 20.13, 20.15, 20.17, 20.24, 20.29, 20.37, 20.39, 20.41, 20.42 (**C**H~3~CH); 59.48, 59.49, 59.68, 59.80, 59.84, 60.01, 60.17, 60.57, 60.67, 60.69, 61.03, 61.06, 61.12, 61.19, 61.21, 61.33, 61.34 (CH~3~**C**H~2~O); 61.62, 61.74, 61.82, 62.00, 62.58, 62.63, 63.66, 64.18 (CH~2~-6); 66.71, 68.04, 68.34, 68.52, 69.56, 69.67, 69.93 (CH-3,4); 75.61, 75.77, 75.82, 76.06, 76.34, 76.40, 76.57, 76.70 (CH-5); 98.13, 98.15, 99.59, 99.63, 99.73, 99.70, 99.73, 99.76, 99.80, 99.91, 99.93, 99.97, 100.01, 100.07, 100.11, 100.16, 100.21, 100.31, 100.87, 100.92, 100.97, 100.98 (CH-2, CH~3~**C**H); 143.64, 143.80, 143.81, 143.87, 144.04, 144.05 (CH-1); IR (CHCl~3~): ν~max~ 3069, 2980, 2933, 2898, 1644, 1484, 1454, 1445, 1394, 1383, 1340, 1298, 1254, 1235, 1134, 1094, 1082, 1055, 1030, 950, 931, 880, 844, 819, 698; HRMS (ESI) *m*/*z* \[M + Na\]^+^ calcd for C~18~H~34~O~7~Na 385.2197, found 385.2197.

### *rac*-(*E*)-6-Hydroxy-1-((2-methoxypropan-2-yl)oxy)-7,7-dimethyloct-2-en-4-one (**4**) {#sec4.1.5}

To a stirred solution of compound **3a** (0.5 g, 1.94 mmol, 1 equiv) in anhydrous THF (10 mL) was added *t*-BuLi (3.99 mL, 6.77 mmol, 3.5 equiv, 1.7 M in pentane) dropwise over 15 min at −78 °C under an argon atmosphere. The reaction mixture was stirred for 10 min at −78 °C and then for 2 h at 0 °C. After warming to RT, Et~3~N (2 mL) was added and the resulting mixture was diluted with EtOAc (100 mL). The organic phase was washed with sat. aq NaHCO~3~ (200 mL) and H~2~O (2 × 200 mL), dried over MgSO~4~, filtered, and concentrated in vacuo. The residue was purified by column chromatography on silica gel (hexane/EtOAc 8:1 to 5:1, 1% Et~3~N) to give enone **4** (854 mg, 81%) as racemic mixture of enantiomers: *R~f~* = 0.44 (hexane/EtOAc 3:1); \[α\]~D~^20^ 9.4 (*c* 0.3, CHCl~3~); ^1^H NMR (500.0 MHz, DMSO-*d*~6~): 0.83 (s, 9H, ((CH~3~)~3~)C); 1.29 (s, 6H, (CH~3~)~2~C); 2.52 (dd, 1H, ^2^*J* = 15.3, ^3^*J* = 2.7, CH~a~**H**~**b**~CHOH); 2.60 (dd, 1H, ^2^*J* = 15.3, ^3^*J* = 9.5, C**H**~**a**~H~b~CHOH); 3.08 (s, 3H, CH~3~O); 3.60 (ddd, 1H, ^3^*J* = 9.5, 5.9, 2.8, CH~2~C**H**OH); 4.09 (dd, 2H, ^3^*J* = 4.3, ^4^*J* = 2.1, C**H**~**2**~--CH=CH); 4.54 (d, 1H, ^3^*J* = 5.9, CH~2~CHO**H**); 6.32 (dt, 1H, ^3^*J* = 16.0, ^4^*J* = 2.1, CH~2~--CH=C**H**); 6.84 (dt, 1H, ^3^*J* = 16.0, 4.3, CH~2~--C**H**=CH); ^13^C NMR (125.7 MHz, DMSO-*d*~6~): 24.4 ((**C**H~3~)~3~C); 26.0 ((**C**H~3~)~2~C); 35.0 ((CH~3~)~3~**C**); 42.9 (**C**H~2~CHOH); 48.2 (CH~3~O); 59.7 (**C**H~2~--CH=CH); 74.5 (CH~2~**C**HOH); 100.1 ((CH~3~)~2~**C**); 129.2 (CH~2~--CH=**C**H); 143.7 (CH~2~--**C**H=CH); 199.8 (CO); IR (CHCl~3~): ν~max~ 3054, 2989, 2956, 2909, 2879, 2873, 1690, 1665, 1634, 1480, 1466, 1381, 1368, 1292, 1192, 1065, 969 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\]^+^ calcd for C~14~H~26~O~4~Na 281.1723, found 281.1723.

### (1,5-Anhydro-2-deoxy-3,4,6-tri-*O*-(2-methoxypropan-2-yl)-[d]{.smallcaps}-arabino-hex-1-enitolyl)boronic Acid Pinacol Ester (**5a**) {#sec4.1.6}

To a stirred solution of MOP-glucal **2a** (1 g, 2.76 mmol, 1 equiv) in anhydrous THF (20 mL) was added *t*-BuLi (5.68 mL, 9.66 mmol, 3.5 equiv, 1.7 M in pentane) dropwise over 10 min at −78 °C under argon atmosphere. The reaction mixture was stirred for 10 min at −78 °C and then for 1 h at 0 °C. Subsequently, the resulting mixture was again cooled to −78 °C and iPrOBpin (2.25 mL, 11.04 mmol, 4 equiv) was added dropwise over 10 min. The mixture was allowed to warm gradually to RT over 3 h and stirred overnight. The reaction was quenched by the addition of H~2~O (5 mL) and extracted between EtOAc (200 mL) and H~2~O (200 mL). The organic layer was washed with H~2~O (2 × 200 mL), dried over MgSO~4~, filtered, and concentrated in vacuo to give crude product **5a** (1.27 g, 94%) as a pale yellow oil, which was used without further purification for the next step: \[α\]~D~^20^ −17.9 (*c* 0.3, CHCl~3~); IR (CHCl~3~): ν~max~ 2995, 2985, 2957, 2833, 1644, 1468, 1447, 1402, 1391, 1381, 1373, 1330, 1235, 1144, 1144, 1099, 1099, 1079, 1049, 1027, 966, 866 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\]^+^ calcd for C~24~H~45~O~9~BNa 511.3049, found 511.3051.

### (1,5-Anhydro-2-deoxy-3,4,6-tri-*O*-(ethoxyethyl)-[d]{.smallcaps}-arabino-hex-1-enitolyl)boronic Acid Pinacol Ester (**5b**) {#sec4.1.7}

To a stirred solution of EE-glucal **2b** (3 g, 8.28 mmol, 1 equiv) in anhydrous THF (20 mL) was added *t*-BuLi (17.04 mL, 28.97 mmol, 3.5 equiv, 1.7 M in pentane) dropwise over 10 min at −78 °C under argon atmosphere. The reaction mixture was stirred for 10 min at −78 °C and then for 1 h at 0 °C. Subsequently, the resulting mixture was again cooled to −78 °C and iPrOBpin (6.75 mL, 33.11 mmol, 4 equiv) was added dropwise over 5 min. The mixture was allowed to warm gradually to RT over 3 h and stirred overnight. The reaction was quenched by the addition of H~2~O (5 mL) and extracted between EtOAc (150 mL) and H~2~O (100 mL). The organic layer was washed with H~2~O (2 × 100 mL), dried over MgSO~4~, filtered, and concentrated in vacuo to give crude product **5b** (3.26 g, 81%) as a pale yellow oil, which was used without further purification for the next step: IR (CHCl~3~): ν~max~ 3614, 3574, 2982, 2935, 1732, 1642, 1480, 1405, 1396, 1382, 1374, 1340, 1141, 1135, 1095, 1084, 1055, 1055, 962, 861 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\]^+^ calcd for C~24~H~45~O~9~BNa 511.3049, found 511.3055.

### 1,5-Anhydro-2-deoxy-3,4,6-tri-*O*-(2-methoxypropan-2-yl)-1-(tri-*n*-butylstannyl)-[d]{.smallcaps}-arabino-hex-1-enitol (**6a**) {#sec4.1.8}

To a stirred solution of MOP-glucal **2a** (3 g, 8.28 mmol, 1 equiv) in anhydrous THF (20 mL) was added *t*-BuLi (17.04 mL, 28.97 mmol, 3.5 equiv, 1.7 M in pentane) dropwise over 15 min at −78 °C under argon atmosphere. The reaction mixture was stirred for 10 min at −78 °C and then for 1 h at 0 °C. Subsequently, the resulting mixture was again cooled to −78 °C and Bu~3~SnCl (8.98 mL, 31.11 mmol, 4 equiv) was added dropwise over 10 min. The mixture was allowed to warm gradually to RT over 3 h and stirred for 2 h. Et~3~N (5 mL) was added, and the resulting mixture was stirred for another 20 min at RT and then diluted with EtOAc (250 mL). The organic layer was washed with NaHCO~3~ (250 mL), H~2~O (250 mL), and brine (250 mL), dried over MgSO~4~, and filtered and concentrated in vacuo. The residue was purified by column chromatography on silica gel (hexane/EtOAc 20:1, 1% Et~3~N) to give product **6a** (5.02, 93%) as a light-yellow oil: *R~f~* = 0.69 (hexane/EtOAc 3:1); \[α\]~D~^20^ −44.6 (*c* 0.3, CHCl~3~); ^1^H NMR (401.0 MHz, DMSO-*d*~6~): 0.86 (t, 9H, *J*~vic~ = 7.3, C**H**~**3**~CH~2~CH~2~CH~2~Sn); 0.85--0.94 (m, 6H, CH~3~CH~2~CH~2~C**H**~**2**~Sn); 1.21--1.34 (m, 24H, (CH~3~)~2~C, CH~3~C**H**~**2**~CH~2~CH~2~Sn); 1.40--1.62 (m, 6H, CH~3~CH~2~C**H**~**2**~CH~2~Sn); 3.08, 3.14 (2 × s, 9H, CH~3~O); 3.52 (dd, 1H, *J*~6b,6a~ = 10.3, *J*~6b,5~ = 5.1, H-6b); 3.59 (dd, 1H, *J*~6a,6b~ = 10.3, *J*~6a,5~ = 7.5, H-6a); 3.72 (dt, 1H, *J*~3,2~ = 5.1, *J*~3,4~ = *J*~3,5~ = 2.1, H-3); 3.91 (td, 1H, *J*~4,3~ = *J*~4,5~ = 2.1, *J*~4,2~ = 1.6, H-4); 4.07 (ddt, 1H, *J*~5,6a~ = 7.5, *J*~5,6b~ = 5.2, *J*~5,3~ = *J*~5,4~ = 2.1, H-5); 4.79 (dd, 1H, *J*~2,3~ = 5.1, *J*~2,4~ = 1.6, H-2); ^13^C NMR (100.8 MHz, DMSO-*d*~6~): 9.4 (CH~3~CH~2~CH~2~**C**H~2~Sn); 13.8 (**C**H~3~CH~2~CH~2~CH~2~Sn); 24.6, 24.4, 25.0, 25.1, 25.1, 25.3 ((**C**H~3~)~2~C); 26.7 (CH~3~**C**H~2~CH~2~CH~2~Sn); 28.6 (CH~3~CH~2~**C**H~2~CH~2~Sn); 47.8, 48.5, 48.8 (CH~3~O); 59.2 (CH~2~-6); 61.9 (CH-3); 67.6 (CH-4); 76.8 (CH-5); 99.4; 100.2, 100.8 ((CH~3~)~2~**C**); 111.5 (CH-2); 162.3 (C-1); IR (CHCl~3~): ν~max~ 2994, 2958, 2932, 2827, 1465, 1433, 1381, 1373, 1151, 1104, 1072, 1011, 891, 870, 857, 843, 824, 515 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\]^+^ calcd for C~30~H~60~O~7~NaSn 675.3253, found 675.3260.

### 1,5-Anhydro-2-deoxy-3,4,6-tri-*O*-(ethoxyethyl)-1-(tri-*n*-butylstannyl)-[d]{.smallcaps}-arabino-hex-1-enitol (**6b**) {#sec4.1.9}

To a stirred solution of EE-glucal **2b** (2 g, 5.52 mmol, 1 equiv) in anhydrous THF (15 mL) was added *t*-BuLi (11.36 mL, 19.31 mmol, 3.5 equiv, 1.7 M in pentane) dropwise over 10 min at −78 °C under argon atmosphere. The reaction mixture was stirred for 20 min at −78 °C and then for 3 h at 0 °C. Subsequently, the resulting mixture was again cooled to −78 °C and Bu~3~SnCl (5.99 mL, 22.07 mmol, 4 equiv) was added dropwise over 10 min. The mixture was allowed to warm gradually to RT over 3 h and stirred for 1 h. Et~3~N (5 mL) was added, and the resulting mixture was stirred for another 30 min at RT and then diluted with EtOAc (100 mL). The organic layer was washed with sat. aq NaHCO~3~ (50 mL), H~2~O (100 mL), and brine (250 mL), dried over MgSO~4~, filtered, and concentrated in vacuo. The residue was purified by column chromatography on silica gel (hexane/EtOAc 20:1, 1% Et~3~N) to give product **6b** (2.89, 81%) as a yellow oil: *R~f~* = 0.65 (hexane/EtOAc 4:1); ^1^H NMR (401.0 MHz, CDCl~3~): 0.83--0.96 (m, 15H, C**H**~**3**~CH~2~CH~2~C**H**~**2**~Sn); 1.16--1.21 (m, 9H, C**H**~**3**~CH~2~O); 1.26--1.35 (m, 15H, C**H**~**3**~CH, CH~3~C**H**~**2**~CH~2~CH~2~Sn); 1.42--1.61 (m, 6H, CH~3~CH~2~C**H**~**2**~CH~2~Sn); 3.41--4.00 (m, 10H, H-4,5,6, CH~3~C**H**); 4.03--4.24 (m, 1H, H-3); 4.65--5.05 (m, 1H, H-2); ^13^C NMR (100.8 MHz, CDCl~3~): 9.57, 9.60, 9.62 (CH~3~CH~2~CH~2~**C**H~2~Sn); 13.65, 13.66 (**C**H~3~CH~2~CH~2~CH~2~Sn); 15.28, 15.30, 15.31, 15.35, 15.38 (**C**H~3~CH~2~O); 19.83, 19.85, 19.90, 19.93, 19.96, 20.00, 20.40, 20.44, 20.57, 20.59, 20.60, 20.71, 20.75, 20.80, 20.82, 20.84, 20.97, 21.01 (**C**H~3~CH); 27.19, 27.20 (CH~3~**C**H~2~CH~2~CH~2~Sn); 28.88 (CH~3~CH~2~**C**H~2~CH~2~Sn); 59.67, 59.73, 59.76, 59.82, 60.37, 60.40, 60.44, 60.47, 60.63, 60.64, 60.65, 60.68, 60.80, 60.82, 60.99, 61.09, 61.41, 61.49, 61.59, 61.62, 61.82, 61.93, 62.34 (CH~3~**C**H~2~O); 63.35, 63.46, 64.03, 64.21, 64.26, 64.85, 65.03 (CH~2~-6); 69.26, 70.05, 71.15, 71.38, 71.60, 71.72, 71.74, 71.93, 72.00, 72.10, 72.24, 72.40, 73.25, 74.12, 75.27, 75.66, 76.56, 76.75, 76.92, 77.05, 77.20, 77.25, 77.29, 77.36 (CH-3,4,5); 97.29, 97.31, 97.48, 97.51, 99.59, 99.83, 99.86, 99.91, 99.92, 99.96, 99.99, 100.01, 100.23, 100.27, 100.30, 100.33, 100.41, 100.55, 100.58 (CH~3~**C**H); 109.87, 110.18, 110.26, 110.32, 111.83, 111.95, 112.14, 112.36 (CH-2); 163.90, 164.07, 164.16, 164.22, 164.25, 164.27, 164.36 (C-1); IR (CHCl~3~): ν~max~ 2979, 2931, 2897, 2852, 1606, 1464, 1457, 1379, 1246, 1131, 1097, 1097, 1055, 1055, 1030 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\]^+^ calcd for C~30~H~60~O~7~NaSn 675.3253, found 675.3255.

### (1,5-Anhydro-2-deoxy-3,4,6-tri-*O*-(ethoxyethyl)-[d]{.smallcaps}-lyxo-hex-1-enitolyl)boronic Acid Pinacol Ester (**7**) {#sec4.1.10}

To a stirred solution of EE-galactal **3b** (2 g, 5.52 mmol, 1 equiv) in anhydrous THF (15 mL) was added *t*-BuLi (11.36 mL, 19.31 mmol, 3.5 equiv, 1.7 M in pentane) dropwise over 5 min at −78 °C under argon atmosphere. The reaction mixture was stirred for 5 min at −78 °C and then for 30 h at 0 °C. Subsequently, the resulting mixture was again cooled to −78 °C and iPrOBpin (4.50 mL, 22.07 mmol, 4 equiv) was added dropwise over 5 min. The mixture was allowed to warm gradually to RT over 3 h and stirred overnight. The reaction was quenched by the addition of H~2~O (5 mL) and extracted between EtOAc (100 mL) and H~2~O (100 mL). The organic layer was washed with H~2~O (2 × 200 mL), dried over MgSO~4~, filtered, and concentrated in vacuo to give crude product **7** (2.42 g, 90%) as a red-brown oil, which was used without further purification for the next step: IR (CHCl~3~): ν~max~ 2981, 2936, 1477, 1471, 1402, 1391, 1391, 1382, 1374, 1296, 1167, 1138, 1112, 1094, 1083, 1008, 866, 851, 851 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\]^+^ calcd for C~24~H~45~O~9~BNa 511.3049, found 511.3051.

### 1,5-Anhydro-2-deoxy-3,4,6-tri-*O*-(ethoxyethyl)-1-(tri-*n*-butylstannyl)-[d]{.smallcaps}-lyxo-hex-1-enitol (**8**) {#sec4.1.11}

To a stirred solution of EE-galactal **3b** (2.5 g, 6.90 mmol, 1 equiv) in anhydrous THF (15 mL) was added *t*-BuLi (14.20 mL, 24.14 mmol, 3.5 equiv, 1.7 M in pentane) dropwise over 5 min at −78 °C under argon atmosphere. The reaction mixture was stirred for 5 min at −78 °C and then for 30 min at 0 °C. Subsequently, the resulting mixture was again cooled to −78 °C and Bu~3~SnCl (7.48 mL, 27.59 mmol, 4 equiv) was added dropwise over 10 min. The mixture was allowed to warm gradually to RT over 3 h and stirred for 2 h. The resulting mixture was diluted with EtOAc (150 mL) and washed with sat. aq NaHCO~3~ (100 mL), H~2~O (100 mL), and brine (100 mL), dried over MgSO~4~, filtered, and concentrated in vacuo. The residue was purified by column chromatography on silica gel (hexane/EtOAc 15:1, 1% Et~3~N) to give product **8** (3.10, 69%) as a red-brown oil: *R~f~* = 0.80 (hexane/EtOAc 3:1); ^1^H NMR (401.0 MHz, acetone-*d*~6~): 0.90 (t, 9H, *J*~vic~ = 7.3, C**H**~**3**~CH~2~CH~2~CH~2~Sn); 0.94--1.01 (m, 6H, CH~3~CH~2~CH~2~C**H**~**2**~Sn); 1.10--1.18 (m, 9H, C**H**~**3**~CH~2~O); 1.22--1.29 (m, 9H, C**H**~**3**~CH); 1.30--1.40 (m, 6H, CH~3~C**H**~**2**~CH~2~CH~2~Sn); 1.47--1.69 (m, 6H, CH~3~CH~2~C**H**~**2**~CH~2~Sn); 3.40--3.91 (m, 8H, H-6, CH~3~C**H**~**2**~O); 3.94--4.38 (m, 3H, H-3,4,5); 4.65--5.13 (m, 4H, H-2, CH~3~C**H**); ^13^C NMR (100.8 MHz, acetone-*d*~6~): 10.10, 10.12, 10.13, 10.14 (CH~3~CH~2~CH~2~**C**H~2~Sn); 13.94, 13.96, 13.97 (**C**H~3~CH~2~CH~2~CH~2~Sn); 15.71, 15.73, 15.75, 15.78, 15.82 (**C**H~3~CH~2~O); 20.29, 20.30, 20.45, 20.50, 20.53, 20.61, 20.66, 20.72, 20.76, 20.79, 20.83, 20.87, 20.93, 21.08, 21.09 (**C**H~3~CH); 27.79, 27.80, 27.82, 27.84 (CH~3~**C**H~2~CH~2~CH~2~Sn); 29.60, 29.61 (CH~3~CH~2~**C**H~2~CH~2~Sn); 60.19, 60.24, 60.62, 60.75, 60.78, 60.93, 60.98, 61.11, 61.21, 61.22, 61.26, 61.31, 61.35, 61.39, 62.04, 62.08, 62.14 (CH~3~**C**H~2~O); 63.68, 64.29, 64.79, 64.81, 65.29, 65.55, 65.73 (CH~2~-6); 69.93, 69.98, 70.05, 70.98, 71.22, 71.40, 76.82, 76.94, 77.12, 77.28, 77.37, 77.75, 77.81 (CH-3,4,5); 99.34, 99.47, 100.18, 100.25, 100.27, 100.35, 100.39, 100.45, 100.62, 100.72, 100.77, 100.79, 100.88, 100.92, 101.00 (CH~3~**C**H); 112.10, 112.29, 112.33, 112.91, 112.95, 113.11 (CH-2); 163.08, 163.11, 163.28, 163.31, 163.32 (C-1); IR (CHCl~3~): ν~max~ 3040, 2978, 2959, 2931, 2920, 2900, 2872, 1855, 1600, 1483, 1465, 1457, 1445, 1417, 1395, 1379, 1293, 1176, 1133, 1096, 1096, 1082, 1068, 1056, 843, 650, 599, 510 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\]^+^ calcd for C~30~H~60~O~7~NaSn 675.3253, found 675.3254.

General Procedure A: Suzuki Reactions of MOP- and EE-Protected Glycal Pinacol Boronates {#sec4.2}
---------------------------------------------------------------------------------------

To a stirred solution of pinacol boronate (2 equiv) in 1,2-dimethoxyethane (DME) were added 1-iodonaphthalene (1 equiv), Pd(PPh~3~)~2~Cl~2~ (0,05 equiv), and 2 M Na~2~CO~3~ (DME/2 M Na~2~CO~3~ 4:1) under argon atmosphere. The reaction mixture was heated to 80 °C and stirred for 3 h. After TLC analysis showed complete consumption of the starting material, the mixture was cooled to RT, diluted with EtOAc, extracted with H~2~O and brine, dried over MgSO~4~, filtered, and concentrated in vacuo. The residue was purified by column chromatography on silica gel (hexane/EtOAc 10:1 to 6:1).

General Procedure B: Stille Reactions of MOP- and EE-Protected Glycal Stannanes {#sec4.3}
-------------------------------------------------------------------------------

To a solution of stannane (1 equiv) in anhydrous toluene were added 1-iodonaphthalene (1.5 equiv) and Pd(PPh~3~)~4~ (0.05 equiv) under an argon atmosphere. The reaction mixture was stirred under reflux at 125 °C for 5 h. After TLC analysis showed complete consumption of the starting material, the mixture was cooled to RT, filtered through a short plug of celite, and evaporated in vacuo. The residue was purified by column chromatography on silica gel (hexane/EtOAc 10:1 to 6:1).

### (1,5-Anhydro-2-deoxy-3,4,6-tri-*O*-(2-methoxypropan-2-yl)-[d]{.smallcaps}-arabino-hex-1-enitolyl)naphthalene (**9a**) {#sec4.3.1}

From **5a**: Following the general procedure A, boronate **5a** (1.5 g, 3.07 mmol, 2 equiv), 1-iodonaphthalene (0.22 mL, 1.53 mmol, 1 equiv), Pd(PPh~3~)~2~Cl~2~ (54 mg, 77 μmol, 0.05 equiv) in DME (12 mL), and 2 M Na~2~CO~3~ (3 mL) were used. The reaction mixture was stirred at 80 °C for 3 h. After completion of the reaction, the residue was purified by column chromatography on silica gel (hexane/EtOAc 10:1 to 6:1) to give product **9a** (568 mg, 76%) as a pale yellow oil.

From **6a**: Following the general procedure B, stannane **6a** (220 mg, 338 μmol, 1 equiv), 1-iodonaphthalene (74 μL, 507 μmol, 1.5 equiv), and Pd(PPh~3~)~4~ (20 mg, 17 μmol, 0.05 equiv) in toluene (7 mL) were used. The reaction mixture was stirred at 125 °C for 5 h. After completion of the reaction, the residue was purified by column chromatography on silica gel (hexane/EtOAc 10:1 to 6:1) to give product **9a** (142 mg, 86%) as a pale yellow oil: *R~f~* = 0.51 (hexane/EtOAc 3:1); \[α\]~D~^20^ −27.6 (*c* 0.3, CHCl~3~); ^1^H NMR (401.0 MHz, DMSO-*d*~6~): 1.26, 1.31, 1.32, 1.36, 1.42 (5 × s, 18H, (CH~3~)~2~C); 3.05, 3.20, 3.23 (3 × s, 3 × 3H, CH~3~O); 3.63 (dd, 1H, *J*~6b,6a~ = 10.9, *J*~6b,5~ = 3.6, H-6b); 3.97 (dd, 1H, *J*~6a,6b~ = 10.9, *J*~6a,5~ = 8.5, H-6a); 4.07--4.13 (m, 2H, H-3,); 4.45 (ddt, 1H, *J*~5,6~ = 8.5, 3.6, *J*~5,3~ = *J*~5,4~ = 1.9, H-5); 5.06 (dd, 1H, *J*~2,3~ = 5.5, *J*~2,4~ = 1.5, H-2); 7.45--7.57 (m, 4H, H-2,3,6,7-naphth); 7.87--7.97 (m, 2H, H-4,5-naphth); 8.31--8.40 (m, 1H, H-8-naphth); ^13^C NMR (100.8 MHz, DMSO-*d*~6~): 24.39, 24.50, 25.11, 25.19, 25.26 ((**C**H~3~)~2~C); 47.99, 48.79, 49.10 (CH~3~O); 59.03 (CH~2~-6); 62.95 (CH-3); 66.77 (CH-4); 78.29 (CH-5); 99.63, 100.47 ((CH~3~)~2~**C**); 100.69 (CH-2); 101.08 ((CH~3~)~2~**C**); 125.43, 126.10, 126.12, 126.13, 126.33 (CH-2,3,6,7-naphth); 128.21, 129.02 (CH-4,5-naphth); 130.95 (C-8a-naphth); 133.29 (C-4a-naphth); 134.75 (C-1-naphth); 152.26 (C-1); IR (CHCl~3~): ν~max~ 3049, 2995, 2962, 2945, 2886, 2832, 1662, 1508, 1463, 1435, 1435, 1382, 1373, 1258, 1151, 1105, 1095, 1071, 1015, 958, 901, 864, 853, 853, 835, 819, 527, 499 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\]^+^ calcd for C~28~H~40~O~7~Na 511.2666, found 511.2667.

### (1,5-Anhydro-2-deoxy-3,4,6-tri-*O*-(ethoxyethyl)-[d]{.smallcaps}-arabino-hex-1-enitolyl)naphthalene (**9b**) {#sec4.3.2}

From **5b**: Following the general procedure A, boronate **5b** (2.01 g, 4.11 mmol, 2 equiv), 1-iodonaphthalene (0.3 mL, 2.05 mmol, 1 equiv), Pd(PPh~3~)~2~Cl~2~ (72 mg, 103 μmol, 0.05 equiv) in DME (16 mL), and 2 M Na~2~CO~3~ (4 mL) were used. The reaction mixture was stirred at 80 °C for 3 h. After completion of the reaction, the residue was purified by column chromatography on silica gel (hexane/EtOAc 10:1 to 6:1) to give product **9b** (931 mg, 93%) as a pale yellow oil.

From **6b**: Following the general procedure B, stannane **6b** (2 g, 3.07 mmol, 1 equiv), 1-iodonaphthalene (0.67 mL, 4.60 mmol, 1.5 equiv), and Pd(PPh~3~)~4~ (177 mg, 153 μmol, 0.05 equiv) in toluene (15 mL) were used. The reaction mixture was stirred at 125 °C for 5 h. After completion of the reaction, the residue was purified by column chromatography on silica gel (hexane/EtOAc 10:1 to 6:1) to give product **9b** (1.19 g, 79%) as a pale yellow oil.

Preparation of **9b** Using Indium Cross-Coupling Reaction {#sec4.4}
----------------------------------------------------------

To a stirred solution of EE-glucal **2b** (200 mg, 552 μmol, 1 equiv) in anhydrous THF (5 mL) was added *t*-BuLi (0.49 mL, 828 μmol, 1.7 M in pentane, 1.5 equiv) dropwise over 5 min at −78 °C under argon. The reaction mixture was stirred for 15 min at −78 °C and then for 1 h at 0 °C. Subsequently, the resulting mixture was again cooled to −78 °C and transferred via cannula to the solution of InCl~3~ (61 mg, 276 μmol, 0.5 equiv) in THF (4 mL) at −78 °C. The reaction was stirred for 30 min at −78 °C and then allowed to warm to RT. 1-Iodonaphthalene (0.12 mL, 828 μmol, 1.5 equiv) and Pd(Ph~3~P)~2~Cl~2~ (12 mg, 17 μmol, 0.03 equiv) were added, and the resulting mixture was heated to reflux at 70 °C overnight. The mixture was diluted with toluene (10 mL), MeOH (5 mL), filtered over a plug of Celite, and evaporated in vacuo. The residue was purified by column chromatography on silica gel (toluene/acetone 20:1) to give product **9b** (115 mg, 43%) as a pale yellow oil.

Preparation of **9b** Using Negishi Cross-Coupling Reaction {#sec4.5}
-----------------------------------------------------------

To a stirred solution of EE-glucal **2b** (200 mg, 552 μmol, 1 equiv) in anhydrous THF (5 mL) was added *t*-BuLi (1.14 mL, 1.93 mmol, 1.7 M in pentane, 3.5 equiv) dropwise over 5 min at −78 °C under argon. The reaction mixture was stirred for 15 min at −78 °C and then for 1 h at 0 °C. Then, a solution of freshly fused ZnCl~2~ (301 mg, 2.21 mmol, 4 equiv) in THF (4 mL) was added at 0 °C. In a separate flask, Pd(PPh~3~)~4~ (32 mg, 28 μmol, 0.05 equiv) and 1-iodonaphthalene (97 μL, 662 μmol, 1.2 equiv) were dissolved in THF (1 mL), giving a red-brown solution. To this solution was transferred the solution containing the organozinc compound via cannula at RT and stirred for 2 h. The reaction mixture was diluted with EtOAc (50 mL) and filtered over a plug of Celite. The filtrate was washed with H~2~O (2 × 50 mL) and brine (50 mL), dried over MgSO~4~, filtered, and evaporated in vacuo. The residue was purified by column chromatography on silica gel (hexane/EtOAc 6:1) to give product **9b** (54 mg, 20%) as a pale yellow oil: *R~f~* = 0.37 (hexane/EtOAc 4:1); ^1^H and ^13^C NMR spectra of **9b** were analyzed after in situ deprotection by 10% CD~3~COOD in CD~3~OD (see [SI](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b00901/suppl_file/ao8b00901_si_001.pdf) Chapter 4), and NMR spectra were compared with the spectra of unprotected derivative **12**; IR (CHCl~3~): ν~max~ 3061, 3050, 2980, 2933, 2899, 2887, 2875, 2860, 2855, 1662, 1593, 1580, 1508, 1484, 1466, 1445, 1397, 1382, 1241, 1130, 1096, 1084, 1056, 868, 844, 694 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\]^+^ calcd for C~28~H~40~O~7~Na 511.2666, found 511.2666.

### (1,5-Anhydro-2-deoxy-3,4,6-tri-*O*-(ethoxyethyl)-[d]{.smallcaps}-lyxo-hex-1-enitolyl)naphthalene (**10**) {#sec4.5.1}

From **7**: Following the general procedure A, boronate **7** (1.35 g, 2.76 mmol, 2 equiv), 1-iodonaphthalene (0.20 mL, 1.38 mmol, 1 equiv), Pd(PPh~3~)~2~Cl~2~ (48 mg, 69 μmol, 0.05 equiv) in DME (12 mL), and 2 M Na~2~CO~3~ (3 mL) were used. The reaction mixture was stirred at 80 °C for 3 h. After completion of the reaction, the residue was purified by column chromatography on silica gel (hexane/EtOAc 8:1, 1% Et~3~N) to give product **10** (584 mg, 87%) as a pale yellow oil.

From **8**: Following the general procedure B, stannane **8** (800 mg, 1.23 mmol, 1 equiv), 1-iodonaphthalene (0.27 mL, 1.84 mmol, 1.5 equiv), and Pd(PPh~3~)~4~ (71 mg, 61 μmol, 0.05 equiv) in toluene (15 mL) were used. The reaction mixture was stirred at 125 °C for 5 h. After completion of the reaction, the residue was purified by column chromatography on silica gel (hexane/EtOAc 8:1, 1% Et~3~N) to give product **10** (432 mg, 72%) as a pale yellow oil: *R~f~* = 0.38 (hexane/EtOAc 4:1); ^1^H and ^13^C NMR spectra of **10** were analyzed after in situ deprotection by 10% CD~3~COOD in CD~3~OD (see [SI](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b00901/suppl_file/ao8b00901_si_001.pdf) Chapter 4), and NMR spectra were compared with the NMR of unprotected derivative **15**; IR (CHCl~3~): ν~max~ 3090, 3062, 3049, 2981, 2933, 2898, 2874, 1661, 1621, 1593, 1581, 1508, 1483, 1456, 1446, 1395, 1381, 1134, 1112, 1100, 1084, 1056, 861, 804, 640 cm^--1^; HRMS (ESI) \[M + Na\]^+^*m*/*z* calcd for C~28~H~40~O~7~Na 511.2666, found 511.2667.

### (1,5-Anhydro-2-deoxy-[d]{.smallcaps}-arabino-hex-1-enitolyl)naphthalene (**12**) {#sec4.5.2}

From **9a**: The derivative **9a** (250 mg, 512 μmol) was dissolved in the mixture of THF (5 mL) and 1% AcOH (5 mL). The reaction mixture was stirred at RT overnight. The reaction mixture was diluted with EtOAc (100 mL) and washed with H~2~O (2 × 50 mL). The organic layer was dried over MgSO~4~, filtered, and concentrated in vacuo. The residue was purified by column chromatography on silica gel (CHCl~3~/MeOH 8:1) to give product **12** (127 mg, 91%) as a colorless oil.

From **9b**: The derivative **9b** (180 mg, 368 μmol) was dissolved in the mixture of THF (5 mL) and 20% AcOH (5 mL). The reaction mixture was stirred at RT overnight. The reaction mixture was diluted with EtOAc (100 mL) and washed with H~2~O (2 × 50 mL). The organic layer was dried over MgSO~4~, filtered, and concentrated in vacuo. The residue was purified by column chromatography on silica gel (CHCl~3~/MeOH 8:1) to give product **12** (90 mg, 90%) as a colorless oil: *R~f~* = 0.61 (CHCl~3~/MeOH 3:1); \[α\]~D~^20^ −11.9 (c 0.3, MeOH); ^1^H NMR (401.0 MHz, CD~3~OD): 3.84 (dd, 2H, *J*~4,5~ = 9.8, *J*~4,3~ = 7.1, H-4); 3.93 (dd, 1H, *J*~6b,6a~ = 12.3, *J*~6b,5~ = 5.3, H-6b); 4.00 (dd, 1H, *J*~6a,6b~ = 12.3, *J*~6a,5~ = 2.6, H-6a); 4.10 (ddd, 1H, *J*~5,4~ = 9.8, *J*~5,6~ = 5.3, 2.6, H-5); 4.37 (dd, 1H, *J*~3,4~ = 7.1, *J*~3,4~ = 2.5, H-3); 5.02 (d, 1H, *J*~2,3~ = 2.5, H-2); 7.43 (dd, 1H, *J*~3,4~ = 8.3, *J*~3,2~ = 7.0, H-3-naphth); 7.44--7.52 (m, 2H, H-6,7-naphth); 7.55 (dd, 1H, *J*~2,3~ = 7.0, *J*~2,4~ = 1.3, H-2-naphth); 7.82--7.87 (m, 2H, H-4,5-naphth); 8.23 (m, 1H, H-8-naphth); ^13^C NMR (100.8 MHz, CD~3~OD): 62.3 (CH~2~-6); 71.0 (CH-4); 71.5 (CH-3); 81.3 (CH-5); 105.4 (CH-2); 126.0 (CH-3-naphth); 126.9, 127.00, 127.2 (CH-6,7,8-naphth); 127.8 (CH-2-naphth); 129.2 (CH-5-naphth); 130.2 (CH-4-naphth); 132.6 (C-8a-naphth); 135.0, 135.1 (C-1,4a-naphth); 155.0 (C-1); IR (CHCl~3~): ν~max~ 3278, 1659, 1621, 1590, 1509, 1400, 1253, 1108, 1067, 1067, 1047, 800 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\]^+^ calcd for C~16~H~16~O~4~Na 295.0941, found 295.0941.

### (1,5-Anhydro-2-deoxy-[d]{.smallcaps}-lyxo-hex-1-enitolyl)naphthalene (**15**) {#sec4.5.3}

EE-protected derivative **10** (186 mg, 381 μmol) was dissolved in 10% AcOH in MeOH (10 mL). The reaction mixture was heated to 40 °C and stirred for 1.5 h. After cooling to RT, toluene (30 mL) was added and the solution was evaporated in vacuo. The residue was purified by column chromatography on silica gel (CHCl~3~/MeOH 12:1 to 10:1, 1% Et~3~N) to give product **15** (61 mg, 59%) as a colorless oil: *R~f~* = 0.68 (CHCl~3~/MeOH 5:1); \[α\]~D~^20^ −6.2 (c 0.4, MeOH); ^1^H NMR (401.0 MHz, CD~3~OD): 3.90 (dd, 1H, *J*~6b,6a~ = 11.5, *J*~6b,5~ = 5.8, H-6b); 3.94 (dd, 1H, *J*~6a,6b~ = 11.5, *J*~6a,5~ = 6.6, H-6a); 4.06 (ddd, 1H, *J*~4,3~ = 4.7, *J*~4,2~ = 1.9, *J*~4,5~ = 1.1, H-4); 4.24 (ddt, 1H, *J*~5,6~ = 6.6, 5.8, *J*~5,3~ = *J*~5,4~ = 1.1, H-5); 4.59 (dd, 1H, *J*~3,4~ = 4.7, *J*~3,2~ = 2.4, H-3); 4.93 (dd, 1H, *J*~2,3~ = 2.4, *J*~2,1~ = 1.9, H-2); 7.43 (dd, 1H, *J*~3,4~ = 8.4, *J*~3,2~ = 7.0, H-3-naphth); 7.43--7.50 (m, 2H, H-6,7-naphth); 7.55 (dd, 1H, *J*~2,3~ = 7.0, *J*~2,4~ = 1.4, H-2-naphth); 7.82--7.87 (m, 2H, H-4,5-naphth); 8.28 (m, 1H, H-8-naphth); ^13^C NMR (100.8 MHz, CD~3~OD): 62.6 (CH~2~-6); 66.1 (CH-4); 66.6 (CH-3); 79.6 (CH-5); 104.6 (CH-2); 126.0 (CH-3-nphth); 126.8 (CH-6-naphth); 127.0 (CH-7-naphth); 127.3 (CH-8-naphth); 127.6 (CH-2-naphth); 129.0 (CH-5-naphth); 130.0 (CH-4-naphth); 132.8 (C-8a-naphth); 135.1 (C-4a-naphth); 135.5 (C-1-naphth); 155.0 (C-1); IR (CHCl~3~): ν~max~ 3361, 1060, 1592, 1508, 1085, 959, 893, 852 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\]^+^ calculated for C~16~H~16~O~4~Na 295.0941, found 295.0941.

Transformations of Endocyclic Double Bond: General Procedure C: Hydroboration {#sec4.6}
-----------------------------------------------------------------------------

To a stirred solution of 1-naphthylglycal (1 equiv) in anhydrous THF was added BH~3~·THF (1 M in THF, 10 equiv) dropwise at 0 °C under argon atmosphere. The reaction mixture was stirred for 2.5 h and 30% NaOH and 30% H~2~O~2~ were added slowly, and the resulting mixture was stirred for 1 h at 0 °C and then for another 2 h at RT. The reaction mixture was diluted with EtOAc and washed with H~2~O (3×). The organic layer was dried over MgSO~4~, filtered, and evaporated in vacuo. The residue was dissolved in the mixture of hexane/EtOAc (3:1) and filtered over a plug of silica gel and evaporated in vacuo. The protected alcohol was confirmed by HRMS and used directly for deprotection (general procedure E or F).

General Procedure D: Epoxidation/LiBHEt~3~ Opening {#sec4.7}
--------------------------------------------------

To a stirred solution of 1-naphthylglycal (1 equiv) in CH~2~Cl~2~ was added freshly distilled solution of DMDO^[@ref23]^ (approx. 0.06 M in acetone, 1.1 equiv) at 0 °C under argon atmosphere. The reaction mixture was stirred for 30 min at 0 °C. Thereafter, the solvent was removed under reduced pressure without heating, codistilled with toluene (3 × 20 mL), and dried for 1 h under vacuum. The residue was dissolved in anhydrous THF, and LiBHEt~3~ (1 M in THF, 40 equiv) was added at 0 °C under argon atmosphere. The reaction mixture was stirred for 30 min at 0 °C and then for 1.5 h at RT. The resulting mixture was diluted with Et~2~O and washed with H~2~O (3×). The organic layer was dried over MgSO~4~, filtered, and evaporated in vacuo. The protected alcohol was confirmed by HRMS and used directly for deprotection (general procedure E or F).

General Procedure E: Deprotection for MOP {#sec4.8}
-----------------------------------------

MOP-protected derivative was dissolved in the mixture of THF and 1% aqueous AcOH (1:1) and stirred at RT overnight. The solution was diluted with H~2~O (10 mL) and evaporated in vacuo. The residue was purified by column chromatography on silica gel (CHCl~3~/MeOH) to give corresponding *C*-glycoside.

General Procedure F: Deprotection for EE {#sec4.9}
----------------------------------------

EE-protected derivative was dissolved in the mixture of THF and 20% aqueous AcOH (1:1) and stirred at RT overnight. The solution was diluted with H~2~O (10 mL) and evaporated in vacuo. The residue was purified by column chromatography on silica gel (CHCl~3~/MeOH) to give corresponding *C*-glycoside.

### 1-(β-[d]{.smallcaps}-Glucopyranosyl)naphthalene (**11**) {#sec4.9.1}

From **9a**: Following the general procedure C, the MOP-protected derivative **9a** (100 mg, 205 μmol, 1 equiv), BH~3~·THF (2.05 mL, 2.05 mmol, 1 M in THF, 10 equiv), and THF (5 mL) were used. The mixture was stirred for 2.5 h at 0 °C. Then, 30% NaOH (2 mL) and 30% H~2~O~2~ (2 mL) were used and resulting mixture was stirred for 1 h at 0 °C and then for 2 h at RT. After completion of the reaction, crude 1-(3,4,6-tri-*O*-(2-methoxypropan-2-yl)-β-[d]{.smallcaps}-glucopyranosyl)naphthalene (*R~f~* = 0.71 (CHCl~3~/MeOH 5:1); HRMS (ESI) *m*/*z* \[M + Na\]^+^ calcd for C~28~H~42~O~8~Na 529.2772, found 529.2772) was obtained. Following the general procedure E, the MOP-*C*-glycoside, THF (5 mL), and 1% AcOH (5 mL) were used. After completion of the reaction, the residue was purified by column chromatography on silica gel (CHCl~3~/MeOH 6:1) to give product **11** (107 mg, 78%) as a colorless foam.

From **9b**: Following the general procedure C, the MOP-protected derivative **9b** (230 mg, 471 μmol, 1 equiv), BH~3~·THF (4.71 mL, 4.71 mmol, 1 M in THF, 10 equiv), and THF (7 mL) were used. The mixture was stirred for 2.5 h at 0 °C. Then, 30% NaOH (5 mL) and 30% H~2~O~2~ (5 mL) were used and resulting mixture was stirred for 1 h at 0 °C and then for 2 h at RT. After completion of the reaction, crude 1-(3,4,6-tri-*O*-(ethoxyethyl)-β-[d]{.smallcaps}-glucopyranosyl)naphthalene (*R~f~* = 0.57 (hexane/EtOAc 2:1); HRMS (ESI) *m*/*z* \[M + Na\]^+^ calcd for C~28~H~42~O~8~Na 529.2772, found 529.2772) was obtained. Following the general procedure E, the EE-*C*-glycoside, THF (10 mL), and 20% AcOH (10 mL) were used. After completion of the reaction, the residue was purified by column chromatography on silica gel (CHCl~3~/MeOH 6:1) to give product **11** (49 mg, 82%) as a colorless foam.

From **12**: Following the general procedure C, the derivative **12** (150 mg, 551 μmol, 1 equiv), BH~3~·THF (5.51 mL, 5.51 mmol, 1 M in THF, 10 equiv), and THF (5 mL) were used. The mixture was stirred for 2.5 h at 0 °C. Then, 30% NaOH (3 mL) and 30% H~2~O~2~ (3 mL) were used and the resulting mixture was stirred for 1 h at 0 °C and then for 2 h at RT. The reaction mixture was diluted with acetone (10 mL) and stirred for 10 min. Then, the formed solid was filtered over a plug of Celite, the plug was washed with MeOH (20 mL), and the filtrate was evaporated in vacuo. The residue was purified by column chromatography on silica gel (CHCl~3~/MeOH 6:1) to give **11** (134 mg, 84%) as a colorless foam: *R~f~* = 0.22 (CHCl~3~/MeOH 5:1); \[α\]~D~^20^ 9.1 (*c* 0.3, MeOH); ^1^H NMR (401.0 MHz, CD~3~OD): 3.51--3.60 (m, 2H, H-4,5); 3.64 (t, 1H, *J*~3,2~ = *J*~3,4~ = 8.6, H-3); 3.74 (dd, 1H, *J*~6b,6a~ = 12.0, *J*~6b,5~ = 5.6, H-6b); 3.82 (dd, 1H, *J*~2,1~ = 9.6, *J*~2,3~ = 8.6, H-2); 3.91 (dd, 1H, *J*~6a,6b~ = 12.0, *J*~6a,5~ = 1.9, H-6a); 4.94 (d, 1H, *J*~1,2~ = 9.6, H-1); 7.42--7.55 (m, 3H, H-3,6,7-naphth); 7.67 (dd, 1H, *J*~2,3~ = 7.2, *J*~2,4~ = 1.4, H-2-naphth); 7.83 (dt, 1H, *J*~4,3~ = 8.4, *J*~4,2~ = *J*~4,5~ = 1.4, H-4-naphth); 7.86 (m, 1H, H-5); 8.31 (m, 1H, H-8); ^13^C NMR (100.8 MHz, CD~3~OD): 63.2 (CH~2~-6); 72.0 (CH-4); 75.8 (CH-2); 80.1 (CH-3); 80.4 (CH-1); 82.5 (CH-5); 125.6 (CH-8-naphth); 126.2 (CH-3-naphth); 126.4 (CH-6-naphth); 126.77 (CH-2-naphth); 126.80 (CH-7-naphth); 129.5, 129.6 (CH-4,5-naphth); 133.5 (C-8a-naphth); 135.4 (C-4a-naphth); 136.3 (C-1-naphth); IR (KBr): ν~max~ 3375, 2924, 1618, 1598, 1512, 1398, 1084, 1084, 1043, 1027, 802 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\]^+^ calcd for C~16~H~18~O~5~Na 313.1046, found 313.1048. Previously published NMR data were measured in CDCl~3~.

### 1-(β-[d]{.smallcaps}-Galactopyranosyl)naphthalene (**14**) {#sec4.9.2}

From **10**: Following the general procedure C, the EE-protected derivative **10** (100 mg, 205 μmol, 1 equiv), BH~3~·THF (2.05 mL, 2.05 mmol, 1 M in THF, 10 equiv), and THF (5 mL) were used. The mixture was stirred for 2.5 h at 0 °C. Then, 30% NaOH (5 mL) and 30% H~2~O~2~ (5 mL) were used and the resulting mixture was stirred for 1 h at 0 °C and then for 2 h at RT. After completion of the reaction, crude 1-(3,4,6-tri-*O*-(ethoxyethyl)-β-[d]{.smallcaps}-galactopyranosyl)naphthalene (*R~f~* = 0.32 (hexane/EtOAc 2:1); HRMS (ESI) *m*/*z* \[M + Na\]^+^ calcd for C~28~H~42~O~8~Na 529.2772, found 529.2773) was obtained. Following the general procedure F, the EE-*C*-glycoside, THF (5 mL), and 20% AcOH (5 mL) were used. After completion of the reaction, the residue was purified by column chromatography on silica gel (CHCl~3~/MeOH 6:1) to give product **14** (41 mg, 69%) as a white solid.

From **15**: Following the general procedure C, the derivative **15** (100 mg, 367 μmol, 1 equiv), BH~3~·THF (3.67 mL, 3.67 mmol, 1 M in THF, 10 equiv), and THF (5 mL) were used. The mixture was stirred for 2.5 h at 0 °C. Then, 30% NaOH (3 mL) and 30% H~2~O~2~ (3 mL) were used and the resulting mixture was stirred for 1 h at 0 °C and then for 2 h at RT. The reaction mixture was diluted with acetone (10 mL) and stirred for 10 min. Then, the formed solid was filtered over a plug of Celite, the plug was washed with MeOH (20 mL), and the filtrate was evaporated in vacuo. The residue was purified by column chromatography on silica gel (CHCl~3~/MeOH 6:1) to give **14** (80 mg, 75%) as a white solid: *R~f~* = 0.20 (CHCl~3~:MeOH 5:1); mp 106--112 °C (acetone) \[α\]~D~^20^ 12.2 (*c* 0.3, MeOH); ^1^H NMR (401.0 MHz, CD~3~OD): 3.72 (dd, 1H, *J*~3,2~ = 9.2, *J*~3,4~ = 3.3, H-3); 3.75--3.86 (m, 3H, H-5,6); 4.08 (dd, 1H, *J*~4,3~ = 3.3, *J*~4,5~ = 0.9, H-4); 4.20 (dd, 1H, *J*~2,1~ = 9.6, *J*~2,3~ = 9.2, H-2); 4.81 (d, 1H, *J*~1,2~ = 9.6, H-1); 7.41--7.53 (m, 3H, H-3,6,7-naphth); 7.68 (dd, 1H, *J*~2,3~ = 7.2, *J*~2,4~ = 1.3, H-2-naphth); 7.83 (dt, 1H, *J*~4,3~ = 8.2, *J*~4,2~ = *J*~4,5~ = 1.3, H-4-naphth); 7.86 (m, 1H, H-5); 8.46 (m, 1H, H-8); ^13^C NMR (100.8 MHz, CD~3~OD): 63.1 (CH~2~-6); 71.2 (CH-4); 72.6 (CH-2); 76.8 (CH-3); 80.8 (CH-5); 82.0 (CH-1); 126.08 (CH-8-naphth); 126.11 (CH-3-naphth); 126.40 (CH-6-naphth); 126.71 (CH-7-naphth); 127.4 (CH-2-naphth); 129.5 (CH-5-naphth); 129.6 (CH-4-naphth); 133.5 (C-8a-naphth); 135.5 (C-4a-naphth); 136.4 (C-1-naphth); IR (MeOH): ν~max~ 3361, 1599, 1512, 1179, 1083, 1048, 1013, 950, 847 cm^--1^; HRMS (ESI) *m*/*z* \[M + Na\]^+^ calcd for C~16~H~18~O~5~Na 313.1046, found 313.1047.

### 1-(α-[d]{.smallcaps}-Glucopyranosyl)naphthalene (**13**) {#sec4.9.3}

From **9a**: Following the general procedure D, the MOP-protected derivative **9a** (200 mg, 409 μmol, 1 equiv), DMDO (7.50 mL, 450 μmol, 0.06 M in acetone, 1.1 equiv), and CH~2~Cl~2~ (5 mL) were used. The mixture was stirred for 30 min at 0 °C. After completion of the epoxidation step, the residue LiBHEt~3~ (16.37 mL, 16.37 mmol, 1 M in THF, 40 equiv) and THF (5 mL) were used. The reaction mixture was stirred for 30 min at 0 °C and then for 1.5 h at RT. After completion of the reaction, crude 1-(3,4,6-tri-*O*-(2-methoxypropan-2-yl)-α-[d]{.smallcaps}-glucopyranosyl)naphthalene (*R~f~* = 0.47 (hexane/EtOAc 3:1); HRMS (ESI) \[M + Na\]^+^*m*/*z* calcd for C~28~H~42~O~8~Na 529.2772, found 529.2772) was obtained. Following the general procedure E, the MOP-*C*-glycoside, THF (5 mL), and 1% AcOH (5 mL) were used. After completion of the reaction, the residue was purified by column chromatography on silica gel (CHCl~3~/MeOH 8:1) to give product **13** (76 mg, 64%) as a colorless oil.

From **9b**: Following the general procedure D, the EE-protected derivative **9b** (140 mg, 287 μmol, 1 equiv), DMDO (5.25 mL, 315 μmol, 0.06 M in acetone, 1.1 equiv), and CH~2~Cl~2~ (5 mL) were used. The mixture was stirred for 30 min at 0 °C. After completion of the epoxidation step, the residue LiBHEt~3~ (11.46 mL, 11.46 mmol, 1 M in THF, 40 equiv) and THF (5 mL) were used. The reaction mixture was stirred for 30 min at 0 °C and then for 1.5 h at RT. After completion of the reaction, crude 1-(3,4,6-tri-*O*-(ethoxyethyl)-α-[d]{.smallcaps}-glucopyranosyl)naphthalene (*R~f~* = 0.53 (CHCl~3~/MeOH 3:1); HRMS (ESI) *m*/*z* \[M + Na\]^+^ calcd for C~28~H~42~O~8~Na 529.2772, found 529.2773) was obtained. Following the general procedure F, the EE-*C*-glycoside, THF (5 mL), and 20% AcOH (5 mL) were used. After completion of the reaction, the residue was purified by column chromatography on silica gel (CHCl~3~/MeOH 8:1) to give product **13** (57 mg, 69%) as a colorless oil: *R~f~* = 0.63 (CHCl~3~/MeOH 3:1); \[α\]~D~^20^ 42.4 (*c* 0.3, CHCl~3~); ^1^H NMR (401.0 MHz, CD~3~OD): 3.51 (ddd, 1H, *J*~5,4~ = 6.9, *J*~5,6~ = 6.1, 3.3, H-5); 3.61--3.69 (m, 2H, H-4,6b); 3.88 (dd, 1H, *J*~6a,6b~ = 12.0, *J*~6a,5~ = 6.1, H-6a); 4.08 (dd, 1H, *J*~2,3~ = 7.1, *J*~2,1~ = 4.2, H-2); 4.23 (dd, 1H, *J*~3,2~ = 7.1, *J*~3,4~ = 6.4, H-3); 5.89 (d, 1H, *J*~1,2~ = 4.2, H-1); 7.42--7.57 (m, 3H, H-3,6,7-naphth); 7.82 (d, 1H, *J*~4,3~ = 8.2, H-4-naphth); 7.88 (m, 1H, H-5-naphth); 7.98 (dt, 1H, *J*~2,3~ = 7.3, *J*~2,4~ = *J*~2,5~ = 1.1, H-2-naphth); 8.28 (m, 1H, H-8-naphth); ^13^C NMR (100.8 MHz, CD~3~OD): 62.1 (CH~2~-6); 71.7 (CH-4); 72.3 (CH-1); 73.8 (CH-2); 74.4 (CH-3); 77.9 (CH-5); 125.2 (CH-8-naphth); 125.6 (CH-3-naphth); 126.4 (CH-6-naphth); 126.9 (CH-7-naphth); 128.1 (CH-2-naphth); 129.2 (CH-4-naphth); 129.8 (CH-5-naphth); 133.0 (C-8a-naphth); 134.4 (C-1-naphth); 135.5 (CH-4-naphth); IR (CHCl~3~): ν~max~ 3606, 3530, 3412, 2928, 1626, 1600, 1592, 1509, 1463, 1401, 1059, 811 cm^--1^; HRMS (ESI) *m*/*z* \[M -- H\]^−^ calcd for C~16~H~17~O~5~ 289.1082, found 289.1080.

### (2*S*,3*R*,4*S*,5*R*)-1-(Naphthalen-1-yl)hexane-1,2,3,4,5,6-hexaol (**16**) {#sec4.9.4}

Following the general procedure D, the EE-protected derivative **10** (180 mg, 368 μmol, 1 equiv), DMDO (6.75 mL, 405 μmol, 0.06 M in acetone, 1.1 equiv), and CH~2~Cl~2~ (5 mL) were used. The mixture was stirred for 30 min at 0 °C. After completion of the epoxidation step, the residue LiBHEt~3~ (14.74 mL, 14.74 mmol, 1 M in THF, 40 equiv) and THF (5 mL) were used. The reaction mixture was stirred for 30 min at 0 °C and then for 1.5 h at RT. After completion of the reaction, crude (2*S*,3*R*,4*S*,5*R*)-1-(naphthalen-1-yl)hexane-(3,4,6-tri-*O*-(ethoxyethyl)-1,2,3,4,5,6-hexaol) (*R~f~* = 0.26 (hexane/EtOAc 5:1); HRMS (ESI) *m*/*z* \[M + Na\]^+^ calcd for C~28~H~44~O~9~Na 547.2878, found 547.2880) was obtained. Following the general procedure F, the hexanol, THF (5 mL), and 20% AcOH (5 mL) were used. After completion of the reaction, the residue was purified by column chromatography on silica gel (CHCl~3~/MeOH 5:1) to give product **16** (59 mg, 52%) as a colorless oil: *R~f~* = 0.15 (CHCl~3~/MeOH 5:1); ^1^H NMR (500.0 MHz, DMSO-*d*~6~): 3.31--3.42 (m, 2H, H-6, overlapped with water signal); 3.49 (bd, 1H, *J*~3,4~ = 9.5, H-3); 3.74 (bt, 1H, *J*~5,6~ = 6.2, H-5); 3.90 (d, 1H, *J*~4,3~ = 9.5, H-4); 4.01 (bd, 1H, *J*~2,1~ = 7.8, H-2); 4.15 (bs, 1H, OH-3); 4.21 (bs, 2H, OH-2,5); 4.51 (bs, 1H, OH-6); 4.69 (bs, 1H, OH-4); 5.37 (d, 1H, *J*~1,2~ = 7.8, H-1); 5.68 (bs, 1H, OH-1); 7.43--7.53 (m, 3H, H-3,6,7-naphth); 7.64 (dd, 1H, *J*~2,3~ = 7.3, *J*~2,4~ = 1.3, H-2-naphth); 7.79 (d, 1H, *J*~4,3~ = 8.2, H-4-naphth); 7.89 (m, 1H, H-5-naphth); 8.26 (m, 1H, H-8-naphth); ^13^C NMR (125.7 MHz, DMSO-*d*~6~): 63.5 (CH~2~-6); 69.1 (CH-4); 69.3 (CH-3); 70.2 (CH-5); 71.2 (CH-1); 72.4 (CH-2); 124.7 (CH-2-naphth); 124.8 (CH-8-naphth); 125.3, 125.4, 125.5 (CH-3,6,7-naphth); 127.1 (CH-4-naphth); 128.5 (CH-5-naphth); 131.7 (C-8a-naphth); 133.4 (CH-4a-naphth); 140.9 (C-1-naphth); HRMS (ESI) *m*/*z* \[M + Na\]^+^calcd for C~16~H~20~O~6~Na 331.1152, found 331.1152.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.8b00901](http://pubs.acs.org/doi/abs/10.1021/acsomega.8b00901).Experimental details and analytical data of the new compounds and their ^1^H and ^13^C NMR spectra ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b00901/suppl_file/ao8b00901_si_001.pdf))

Supplementary Material
======================

###### 

ao8b00901_si_001.pdf

All authors have given approval to the final version of the manuscript.

The authors declare no competing financial interest.

This work was supported by the Czech Science Foundation (reg. No. 15-17572S) and in part by financial support from specific university research (MSMT No. 20-SVV/2017). We also appreciate the support from Gilead Sciences, Inc. provided under the program "Molecules for Life" at the Gilead Sciences & IOCB Prague Research Center.
